Physician profile
Sherlan Thomas
NPI 1972599488
$9,619.82
in general payments reported to CMS, 2019-2025
14 companies · $2,561 in 2025
The $2,561 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $710 · 2022: $1,048 · 2023: $2,710 · 2024: $2,591 · 2025: $2,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,843 · Travel and Lodging: $18.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,843.04 |
| Travel and Lodging | $18.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $4,807.69 | 2022-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $2,231.73 | 2021-2025 | Descovy, Biktarvy, Yeztugo |
| Theratechnologies INC. | $571.65 | 2021-2025 | Egrifta, Trogarzo |
| Janssen Products, LP | $415.63 | 2021-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $408.08 | 2022-2025 | Pifeltro, Delstrigo, Dificid |
| Janssen Biotech, INC. | $352.42 | 2021-2023 | Symtuza |
| Lilly USA, LLC | $241.46 | 2024-2025 | Mounjaro |
| Abbvie INC. | $134.51 | 2021-2023 | |
| Emd Serono, INC. | $104.03 | 2023-2024 | Serostim |
| Napo Pharmaceuticals INC | $95.54 | 2023-2025 | Mytesi |
| Exact Sciences Corporation | $82.52 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $74.92 | 2021-2025 | |
| Madrigal Pharmaceuticals | $54.46 | 2024-2025 | Rezdiffra, Resmetirom |
| Hologic Sales and Service, LLC | $45.18 | 2024 | Aptima, Thinprep 2000 Processor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherlan Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.